ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Intratympanic Drug Therapy Effective for Ménière’s Disease

by David Bronstein • January 15, 2013

  • Tweet
  • Email
Print-Friendly Version

Sudden hearing loss isn’t the only condition that responds to intratympanic (IT) therapy (see "Optimal Usage of Intratympanic Drug Therapy for Sudden Hearing Loss Unclear"). This novel drug delivery method is also effective in easing the vertigo that characterizes Ménière’s disease—a finding that is not surprising given the parallels between the two conditions.

You Might Also Like

No related posts.

Explore This Issue
January 2013

The most fundamental link between Ménière’s and sudden hearing loss is etiology: Both conditions are caused, to varying degrees, by a malfunction of the cochlea and vestibular system; both conditions can fluctuate, making diagnosis and treatment assessments a moving target; and both disorders respond to IT steroid therapy, although for Ménière’s, gentamicin has gained traction due to the aminoglycoside’s ablative effects on vestibular hair cells that are dysfunctional in patients with the balance disorder.

Another parallel between Ménière’s disease and sudden hearing loss is the lack of consensus on the best way to treat the condition. For example, a recent Cochrane review stated that “an effective evidence-based therapy has never been established” for Ménière’s disease (Cochrane Database Syst Rev. 2011;(3):CD008234). But, in reviewing the recent literature on IT gentamicin, the reviewers found two studies that met their main inclusion criteria of being placebo controlled and randomized. Both studies showed a significant reduction in vertigo complaints when compared with placebo, the authors noted. But in one of the trials, 25 percent of patients experienced some hearing loss as a result of gentamicin therapy.

David Haynes, MD, professor in the department of otolaryngology/The Otology Group of Vanderbilt, in Nashville, said the finding of hearing loss is not surprising. Although gentamicin tends to be more vestibulotoxic than ototoxic, “the drug definitely can be ototoxic,” he said. “So I usually try patients on at least a week of systemic medications and [non-drug] interventions to see how they progress before giving them gentamicin—especially if they have a good amount of residual hearing, which you really want to protect.”

In cases in which hearing is present, “I am reluctant to use intratympanic gentamicin unless the patient is really miserable,” Dr. Haynes added. “In fact, I probably use it less than 10 times a year.”

Richard K. Gurgel, MD, assistant professor, division of otolaryngology-head and neck surgery at the University of Utah Health Care in Salt Lake City, agreed that IT gentamicin is usually not a good first-line choice. In fact, “it should be reserved for someone who has failed medical therapy,” he said. That might include a low-sodium diet, he noted, because there is evidence to suggest that Ménière’s is partly caused by a salt and fluid imbalance in the inner ear. Thus, a diuretic may be another first-line option, he said.

Pages: 1 2 | Single Page

Filed Under: Departments, Online Exclusives, Otology/Neurotology, Practice Focus, Special Reports Tagged With: intratympanic drug therapy, Meniere's disease, treatmentIssue: January 2013

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Some Studies Predict a Shortage of Otolaryngologists. Do the Numbers Support Them?
    • Vertigo in the Elderly: What Does It Mean?
    • Complications for When Physicians Change a Maiden Name
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Tympanoplasty Tips: Otology Experts Give Advice on the Procedure
    • How Treatment for Obstructive Sleep Apnea (OSA) Is Evolving to Give Patients a Better Night’s Sleep
    • Vestibular Schwannoma Position Relative to Internal Auditory Canal Helps Predict Postoperative Facial Function
    • Vocal Fold Lipoaugmentation Provides Long-Term Voice Improvements for Glottal Insufficiency
    • Upper Lateral Cartilage Mucosal Flap Enables the Successful Closure of Larger Septal Perforations

Polls

Do you think there will be a shortage of otolaryngologists in the next five to 10 years?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2022 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.